
Genedit
Developer of curative therapies designed for current gene therapy delivery challenges by systematically screening its proprietary nanoparticle library. The company's tool makes therapeutic gene editin...
Valuation
$166M
Latest known
Share Price
N/A
Total Raised
$81M
Last Round
N/A